Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '2510.002.01

Profile

Edit
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
URL https://www.humacyte.com
Investor Relations URL https://humacyte.gcs-web.com/
HQ State/Province North Carolina
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 28, 2025
Last Earnings Release Mar. 28, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
URL https://www.humacyte.com
Investor Relations URL https://humacyte.gcs-web.com/
HQ State/Province North Carolina
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 28, 2025
Last Earnings Release Mar. 28, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows